TXNRD1 and lung adenocarcinoma: First, we compared the cytotoxic effects of the three compounds in lung adenocarcinoma A549 cells, which have an unusually high activity and expression of TXNRD1 that is also known to be able to modulate the cytotoxic efficacy of different anticancer drugs [34,35].